Opko Cost Of Revenue vs Ebitda Analysis

OPK Stock

USD 1.26 0.04 3.28%

Opko Health financial indicator trend analysis is much more than just breaking down Opko Health prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Opko Health is a good investment. Please check the relationship between Opko Health Cost Of Revenue and its Ebitda accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Opko Health. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey.

For more information on how to buy Opko Stock please use our How to buy in Opko Stock guide.

Cost Of Revenue vs Ebitda

Cost Of Revenue vs Ebitda Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Opko Health Cost Of Revenue account and Ebitda. At this time, the significance of the direction appears to have no relationship.

The correlation between Opko Health's Cost Of Revenue and Ebitda is 0.06. Overlapping area represents the amount of variation of Cost Of Revenue that can explain the historical movement of Ebitda in the same time period over historical financial statements of Opko Health, assuming nothing else is changed. The correlation between historical values of Opko Health's Cost Of Revenue and Ebitda is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cost Of Revenue of Opko Health are associated (or correlated) with its Ebitda. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ebitda has no effect on the direction of Cost Of Revenue i.e., Opko Health's Cost Of Revenue and Ebitda go up and down completely randomly.

Correlation Coefficient

0.06

Relationship Direction	Positive
Relationship Strength	Insignificant

View All Relationships

Cost Of Revenue

Cost of Revenue is found on Opko Health income statement and represents the costs associated with goods and services Opko Health provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Ebitda

Most indicators from Opko Health's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Opko Health current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Opko Health. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey.

For more information on how to buy Opko Stock please use our How to buy in Opko Stock guide.At this time, Opko Health's Selling General Administrative is quite stable compared to the past year. Enterprise Value is expected to rise to about 1.5 B this year, although the value of Discontinued Operations will most likely fall to about 93.2 K.

	2021	2022	2023	2024 (projected)
Total Operating Expenses	596M	534.4M	390.2M	199.8M
Cost Of Revenue	1.2B	716M	631.4M	663.0M

Total Operating Expenses Cost Of Revenue

Opko Health fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Common Stock Shares Outstanding	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Intangible Assets	Non Current Liabilities Total	Short Long Term Debt Total	Other Current Assets	Short Term Debt	Common Stock Total Equity	Common Stock	Other Liab	Other Assets
Total Assets		0.81	0.89	1.0	0.89	0.1	-0.64	0.86	0.6	0.99	0.61	0.6	0.78	0.86	0.98	0.67	0.77	0.92	0.89	0.4	0.65	0.47	0.8	0.8	0.85	0.27
Other Current Liab	0.81		0.95	0.79	0.8	0.25	-0.62	0.86	0.34	0.75	0.57	0.34	0.67	0.74	0.82	0.59	0.85	0.74	0.71	0.4	0.78	0.35	0.66	0.68	0.59	0.27
Total Current Liabilities	0.89	0.95		0.89	0.86	0.09	-0.56	0.88	0.41	0.85	0.64	0.41	0.66	0.78	0.87	0.56	0.84	0.85	0.79	0.27	0.78	0.41	0.66	0.66	0.77	0.17
Total Stockholder Equity	1.0	0.79	0.89		0.88	0.05	-0.62	0.84	0.6	0.99	0.63	0.6	0.76	0.86	0.96	0.66	0.76	0.91	0.87	0.35	0.66	0.44	0.78	0.78	0.87	0.24
Property Plant And Equipment Net	0.89	0.8	0.86	0.88		0.36	-0.8	0.94	0.24	0.88	0.49	0.24	0.84	0.94	0.87	0.81	0.65	0.72	0.68	0.5	0.61	0.65	0.85	0.84	0.71	0.46
Net Debt	0.1	0.25	0.09	0.05	0.36		-0.71	0.39	-0.32	0.1	-0.44	-0.32	0.55	0.38	0.22	0.6	0.0	-0.06	0.05	0.89	-0.14	0.55	0.54	0.53	-0.26	0.75
Retained Earnings	-0.64	-0.62	-0.56	-0.62	-0.8	-0.71		-0.79	-0.14	-0.62	-0.16	-0.14	-0.95	-0.88	-0.67	-0.95	-0.49	-0.41	-0.49	-0.81	-0.35	-0.68	-0.93	-0.94	-0.27	-0.82
Accounts Payable	0.86	0.86	0.88	0.84	0.94	0.39	-0.79		0.3	0.81	0.43	0.3	0.84	0.9	0.87	0.84	0.77	0.67	0.68	0.56	0.66	0.57	0.84	0.83	0.71	0.55
Cash	0.6	0.34	0.41	0.6	0.24	-0.32	-0.14	0.3		0.58	0.5	1.0	0.34	0.26	0.6	0.19	0.57	0.64	0.76	0.14	0.39	-0.1	0.37	0.39	0.57	-0.02
Non Current Assets Total	0.99	0.75	0.85	0.99	0.88	0.1	-0.62	0.81	0.58		0.58	0.58	0.76	0.84	0.96	0.63	0.66	0.92	0.89	0.39	0.57	0.46	0.78	0.77	0.85	0.24
Non Currrent Assets Other	0.61	0.57	0.64	0.63	0.49	-0.44	-0.16	0.43	0.5	0.58		0.5	0.26	0.45	0.52	0.18	0.59	0.62	0.55	-0.23	0.86	-0.04	0.27	0.31	0.59	-0.15
Cash And Short Term Investments	0.6	0.34	0.41	0.6	0.24	-0.32	-0.14	0.3	1.0	0.58	0.5		0.34	0.26	0.6	0.19	0.57	0.64	0.76	0.14	0.39	-0.1	0.37	0.39	0.57	-0.02
Common Stock Shares Outstanding	0.78	0.67	0.66	0.76	0.84	0.55	-0.95	0.84	0.34	0.76	0.26	0.34		0.92	0.8	0.91	0.59	0.57	0.64	0.75	0.42	0.68	0.99	1.0	0.47	0.72
Other Stockholder Equity	0.86	0.74	0.78	0.86	0.94	0.38	-0.88	0.9	0.26	0.84	0.45	0.26	0.92		0.83	0.9	0.65	0.66	0.64	0.53	0.57	0.62	0.91	0.91	0.64	0.59
Total Liab	0.98	0.82	0.87	0.96	0.87	0.22	-0.67	0.87	0.6	0.96	0.52	0.6	0.8	0.83		0.68	0.76	0.91	0.92	0.52	0.62	0.51	0.83	0.82	0.79	0.31
Property Plant And Equipment Gross	0.67	0.59	0.56	0.66	0.81	0.6	-0.95	0.84	0.19	0.63	0.18	0.19	0.91	0.9	0.68		0.56	0.38	0.46	0.73	0.37	0.64	0.9	0.91	0.41	0.83
Total Current Assets	0.77	0.85	0.84	0.76	0.65	0.0	-0.49	0.77	0.57	0.66	0.59	0.57	0.59	0.65	0.76	0.56		0.7	0.7	0.26	0.82	0.3	0.6	0.61	0.66	0.21
Intangible Assets	0.92	0.74	0.85	0.91	0.72	-0.06	-0.41	0.67	0.64	0.92	0.62	0.64	0.57	0.66	0.91	0.38	0.7		0.95	0.23	0.62	0.35	0.6	0.59	0.82	-0.04
Non Current Liabilities Total	0.89	0.71	0.79	0.87	0.68	0.05	-0.49	0.68	0.76	0.89	0.55	0.76	0.64	0.64	0.92	0.46	0.7	0.95		0.4	0.56	0.3	0.67	0.66	0.74	0.12
Short Long Term Debt Total	0.4	0.4	0.27	0.35	0.5	0.89	-0.81	0.56	0.14	0.39	-0.23	0.14	0.75	0.53	0.52	0.73	0.26	0.23	0.4		0.03	0.54	0.76	0.75	0.01	0.78
Other Current Assets	0.65	0.78	0.78	0.66	0.61	-0.14	-0.35	0.66	0.39	0.57	0.86	0.39	0.42	0.57	0.62	0.37	0.82	0.62	0.56	0.03		0.22	0.43	0.45	0.57	0.09
Short Term Debt	0.47	0.35	0.41	0.44	0.65	0.55	-0.68	0.57	-0.1	0.46	-0.04	-0.1	0.68	0.62	0.51	0.64	0.3	0.35	0.3	0.54	0.22		0.71	0.65	0.24	0.52
Common Stock Total Equity	0.8	0.66	0.66	0.78	0.85	0.54	-0.93	0.84	0.37	0.78	0.27	0.37	0.99	0.91	0.83	0.9	0.6	0.6	0.67	0.76	0.43	0.71		0.99	0.49	0.68
Common Stock	0.8	0.68	0.66	0.78	0.84	0.53	-0.94	0.83	0.39	0.77	0.31	0.39	1.0	0.91	0.82	0.91	0.61	0.59	0.66	0.75	0.45	0.65	0.99		0.47	0.7
Other Liab	0.85	0.59	0.77	0.87	0.71	-0.26	-0.27	0.71	0.57	0.85	0.59	0.57	0.47	0.64	0.79	0.41	0.66	0.82	0.74	0.01	0.57	0.24	0.49	0.47		-0.01
Other Assets	0.27	0.27	0.17	0.24	0.46	0.75	-0.82	0.55	-0.02	0.24	-0.15	-0.02	0.72	0.59	0.31	0.83	0.21	-0.04	0.12	0.78	0.09	0.52	0.68	0.7	-0.01

Click cells to compare fundamentals

Opko Health Account Relationship Matchups

Opko Health fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	2.3B	2.5B	2.4B	2.2B	2.0B	2.1B
Other Current Liab	143.0M	222.7M	190.9M	143.4M	85.9M	65.4M
Total Current Liabilities	249.1M	375.5M	301.8M	213.5M	200.1M	103.9M
Total Stockholder Equity	1.6B	1.7B	1.7B	1.6B	1.4B	1.5B
Property Plant And Equipment Net	166.5M	178.3M	124.0M	121.6M	143.5M	150.7M
Net Debt	125.7M	149.8M	53.2M	60.3M	230.7M	242.2M
Retained Earnings	(1.5B)	(1.5B)	(1.5B)	(1.8B)	(2.0B)	(1.9B)
Accounts Payable	62.5M	100.9M	82.0M	67M	69.7M	73.2M
Cash	85.5M	72.2M	134.7M	153.2M	95.9M	63.6M
Non Current Assets Total	2.0B	1.9B	1.6B	1.8B	1.7B	1.8B
Non Currrent Assets Other	723.2M	679.1M	465.9M	832.2M	(185.9M)	(176.6M)
Cash And Short Term Investments	85.5M	72.2M	134.7M	153.2M	95.9M	64.0M
Common Stock Shares Outstanding	595.5M	640.7M	648.1M	719.1M	751.8M	789.4M
Liabilities And Stockholders Equity	2.3B	2.5B	2.4B	2.2B	2.0B	2.1B
Other Stockholder Equity	3.1B	3.2B	3.2B	3.4B	3.4B	3.6B
Total Liab	694.5M	801.5M	714.6M	605.7M	622.5M	653.6M
Property Plant And Equipment Gross	166.5M	178.3M	257.3M	264.0M	300.6M	315.7M
Total Current Assets	324M	523.2M	823M	394.5M	309.5M	183.8M
Accumulated Other Comprehensive Income	(22.1M)	(4.2M)	(30.5M)	(43.3M)	(38.0M)	(36.1M)
Intangible Assets	1.3B	1.3B	1.1B	790.9M	935.3M	572.8M
Non Current Liabilities Total	445.4M	426M	412.8M	392.2M	422.4M	222.3M
Short Long Term Debt Total	211.2M	222M	187.9M	213.5M	326.6M	342.9M
Other Current Assets	238.5M	451M	373.3M	241.3M	17.7M	16.8M
Short Term Debt	24.4M	36.2M	28.6M	3.1M	43.1M	45.3M
Common Stock Total Equity	5.9M	6.7M	6.7M	6.9M	7.9M	8.3M
Common Stock	6.7M	6.7M	6.9M	7.8M	7.8M	8.2M
Other Liab	153.8M	204M	196.7M	126.4M	145.4M	142.0M
Other Assets	7.0M	653.7M	465.9M	981.9M	1.1B	1.2B
Property Plant Equipment	144.7M	166.5M	178.3M	124.0M	142.5M	149.7M
Current Deferred Revenue	19.2M	15.8M	258K	1.4M	1.6M	1.5M
Long Term Debt	259.9M	225.8M	187.9M	219.5M	222.0M	121.6M
Net Receivables	157.7M	302.3M	265.6M	148.6M	130.2M	117.8M
Inventory	53.4M	132.3M	86.5M	74.1M	65.7M	42.4M
Good Will	671.9M	680.6M	520.6M	595.9M	598.3M	421.7M
Net Tangible Assets	413.9M	515.9M	574.3M	770.7M	886.3M	930.6M
Retained Earnings Total Equity	(1.2B)	(1.5B)	(1.5B)	(1.5B)	(1.4B)	(1.4B)
Capital Surpluse	3.0B	3.1B	3.2B	3.2B	3.7B	2.5B

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Opko Health is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Opko Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Opko Health Stock. Highlighted below are key reports to facilitate an investment decision about Opko Health Stock:

How To Invest In Opko

Details

Is Opko Stock a good investment?

Details

What is Opko Health's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Opko Health. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey.

For more information on how to buy Opko Stock please use our How to buy in Opko Stock guide.

You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Complementary Tools for Opko Stock analysis

When running Opko Health's price analysis, check to measure Opko Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Opko Health is operating at the current time. Most of Opko Health's value examination focuses on studying past and present price action to predict the probability of Opko Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Opko Health's price. Additionally, you may evaluate how the addition of Opko Health to your portfolios can decrease your overall portfolio volatility.

	AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities
	Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format
	Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios
	Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years
	Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets
	Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios
	Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios

Is Opko Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Opko Health. If investors know Opko will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Opko Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.191

Earnings Share

(0.25)

Revenue Per Share

1.149

Quarterly Revenue Growth

(0.02)

Return On Assets

(0.05)

The market value of Opko Health is measured differently than its book value, which is the value of Opko that is recorded on the company's balance sheet. Investors also form their own opinion of Opko Health's value that differs from its market value or its book value, called intrinsic value, which is Opko Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Opko Health's market value can be influenced by many factors that don't directly affect Opko Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Opko Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Opko Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Opko Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Opko Cost Of Revenue vs Ebitda Analysis

Cost Of Revenue vs Ebitda

Cost Of Revenue vs Ebitda Correlation Analysis

Correlation Coefficient

Cost Of Revenue

Ebitda

Opko Health fundamental ratios Correlations

Opko Health Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Opko Health fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for Opko Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Cash
Common Stock	+ 1.0	Common Stock Shares Outstanding
Non Current Assets Total	+ 0.99	Total Assets
Non Current Assets Total	+ 0.99	Total Stockholder Equity
Common Stock Total Equity	+ 0.99	Common Stock Shares Outstanding

Property Plant And Equipment Gross	- 0.95	Retained Earnings
Common Stock Shares Outstanding	- 0.95	Retained Earnings
Common Stock	- 0.94	Retained Earnings
Common Stock Total Equity	- 0.93	Retained Earnings
Other Stockholder Equity	- 0.88	Retained Earnings
Other Assets	- 0.82	Retained Earnings